Advertisement
Screener

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

2.8 / 5 stars · 68/120 Roast Me

ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 24.71 million shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-08-13

  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 24.71M shares, a 1276.02% increase year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 24.71M shares, a 33.39% decline year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was -17.74M shares.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 10.86M shares, a 53.28% increase year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 20.77M shares, a 30.59% decline from fiscal 2017.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 29.92M shares, a 54.22% increase from fiscal 2016.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 19.40M shares.
  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 21.78M shares, a 287.01% increase from fiscal 2014.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2025-06-3024.71M shares
10-Q · filed 2025-08-13
24.71M shares
10-Q · filed 2025-08-13
31.68M shares
derived: sum of 3 quarters · filed 2025-08-13
42.54M shares
derived: sum of 4 quarters · filed 2025-08-13
2025-03-3124.71M shares
10-Q · filed 2025-05-13
6.97M shares
derived: sum of 2 quarters · filed 2025-05-13
17.83M shares
derived: sum of 3 quarters · filed 2025-05-13
19.62M shares
derived: sum of 4 quarters · filed 2025-08-13
2024-12-31-17.74M shares
derived: 10-Q 12 month − 10-Q 9 month · filed 2025-05-13
-6.88M shares
derived: sum of 2 quarters · filed 2025-05-13
-5.09M shares
derived: sum of 3 quarters · filed 2025-08-13
37.10M shares
10-Q · filed 2025-05-13
2024-09-3010.86M shares
10-Q · filed 2024-11-13
12.65M shares
derived: sum of 2 quarters · filed 2025-08-13
54.84M shares
10-Q · filed 2024-11-13
2024-06-301.80M shares
10-Q · filed 2025-08-13
43.98M shares
10-Q · filed 2025-08-13
2024-03-3137.10M shares
10-Q · filed 2024-05-15
2023-09-307.08M shares
10-Q · filed 2024-11-13
37.33M shares
derived: sum of 2 quarters · filed 2024-11-13
59.07M shares
10-Q · filed 2024-11-13
2023-06-3030.25M shares
10-Q · filed 2024-08-12
52.00M shares
10-Q · filed 2024-08-12
2023-03-3121.76M shares
10-Q · filed 2024-05-15
2022-09-306.00M shares
10-Q · filed 2023-11-08
7.73M shares
derived: sum of 2 quarters · filed 2023-11-08
30.61M shares
10-Q · filed 2023-11-08
2022-06-301.74M shares
10-Q · filed 2023-08-09
24.61M shares
10-Q · filed 2023-08-09
2022-03-3122.88M shares
10-Q · filed 2023-05-12
2021-09-304.17M shares
10-Q · filed 2022-11-08
5.09M shares
derived: sum of 2 quarters · filed 2022-11-08
19.89M shares
10-Q · filed 2022-11-08
2021-06-30918.05K shares
10-Q · filed 2022-08-04
15.72M shares
10-Q · filed 2022-08-04
2021-03-3114.80M shares
10-Q · filed 2022-05-09
2020-09-301.88M shares
10-Q · filed 2021-11-04
4.62M shares
derived: sum of 2 quarters · filed 2021-11-04
14.85M shares
10-Q · filed 2021-11-04
2020-06-302.74M shares
10-Q · filed 2021-08-09
12.97M shares
10-Q · filed 2021-08-09
2020-03-3110.23M shares
10-Q · filed 2021-05-06
2019-09-303.73M shares
10-Q · filed 2020-11-05
4.67M shares
derived: sum of 2 quarters · filed 2020-11-05
15.48M shares
10-Q · filed 2020-11-05
24.06M shares
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30936.70K shares
10-Q · filed 2020-08-06
11.74M shares
10-Q · filed 2020-08-06
20.33M shares
derived: sum of 3 quarters · filed 2020-08-06
21.09M shares
derived: sum of 4 quarters · filed 2020-08-06
2019-03-3110.81M shares
10-Q · filed 2020-05-14
19.39M shares
derived: sum of 2 quarters · filed 2020-05-14
20.15M shares
derived: sum of 3 quarters · filed 2020-05-14
21.58M shares
derived: sum of 4 quarters · filed 2020-05-14
2018-12-318.58M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
9.34M shares
derived: sum of 2 quarters · filed 2019-11-06
10.78M shares
derived: sum of 3 quarters · filed 2019-11-06
20.77M shares
10-K · filed 2019-02-27
2018-09-30757.27K shares
10-Q · filed 2019-11-06
2.19M shares
derived: sum of 2 quarters · filed 2019-11-06
12.19M shares
10-Q · filed 2019-11-06
13.15M shares
derived: sum of 4 quarters · filed 2019-11-06
2018-06-301.44M shares
10-Q · filed 2019-08-01
11.43M shares
10-Q · filed 2019-08-01
12.40M shares
derived: sum of 3 quarters · filed 2019-08-01
21.15M shares
derived: sum of 4 quarters · filed 2019-08-01
2018-03-319.99M shares
10-Q · filed 2019-05-06
10.96M shares
derived: sum of 2 quarters · filed 2019-05-06
19.72M shares
derived: sum of 3 quarters · filed 2019-05-06
20.97M shares
derived: sum of 4 quarters · filed 2019-05-06
2017-12-31965.42K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
9.72M shares
derived: sum of 2 quarters · filed 2019-02-27
10.97M shares
derived: sum of 3 quarters · filed 2019-02-27
29.92M shares
10-K · filed 2019-02-27
2017-09-308.76M shares
10-Q · filed 2018-11-06
10.01M shares
derived: sum of 2 quarters · filed 2018-11-06
28.96M shares
10-Q · filed 2018-11-06
30.61M shares
derived: sum of 4 quarters · filed 2019-02-27
2017-06-301.25M shares
10-Q · filed 2018-08-02
20.20M shares
10-Q · filed 2018-08-02
21.85M shares
derived: sum of 3 quarters · filed 2019-02-27
24.26M shares
derived: sum of 4 quarters · filed 2019-02-27
2017-03-3118.95M shares
10-Q · filed 2018-05-09
20.60M shares
derived: sum of 2 quarters · filed 2019-02-27
23.01M shares
derived: sum of 3 quarters · filed 2019-02-27
24.78M shares
derived: sum of 4 quarters · filed 2019-02-27
2017-03-0815.54M shares
10-K · filed 2017-03-13
2016-12-311.65M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
4.06M shares
derived: sum of 2 quarters · filed 2019-02-27
5.83M shares
derived: sum of 3 quarters · filed 2019-02-27
19.40M shares
10-K · filed 2019-02-27
2016-09-302.41M shares
10-Q · filed 2017-11-02
4.18M shares
derived: sum of 2 quarters · filed 2017-11-02
17.76M shares
10-Q · filed 2017-11-02
17.76M shares
derived: sum of 4 quarters · filed 2018-03-15
2016-06-301.77M shares
10-Q · filed 2017-08-03
15.34M shares
10-Q · filed 2017-08-03
15.34M shares
derived: sum of 3 quarters · filed 2018-03-15
15.34M shares
derived: sum of 4 quarters · filed 2018-03-15
2016-03-3113.58M shares
10-Q · filed 2017-05-10
13.58M shares
derived: sum of 2 quarters · filed 2018-03-15
13.58M shares
derived: sum of 3 quarters · filed 2018-03-15
15.46M shares
derived: sum of 4 quarters · filed 2018-03-15
2015-12-310.00 shares
derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-15
0.00 shares
10-K · filed 2018-03-15
1.89M shares
derived: sum of 3 quarters · filed 2018-03-15
11.07M shares
derived: sum of 4 quarters · filed 2018-03-15
2015-09-300.00 shares
10-Q · filed 2016-11-10
1.89M shares
derived: sum of 2 quarters · filed 2016-11-10
11.07M shares
10-Q · filed 2016-11-10
2015-06-301.89M shares
10-Q · filed 2016-08-08
11.07M shares
10-Q · filed 2016-08-08
21.78M shares
10-K · filed 2018-03-15
2015-03-319.18M shares
10-Q · filed 2016-05-12
2014-06-305.63M shares
10-K · filed 2017-03-13
2013-06-304.04M shares
8-K · filed 2016-07-08